SULFACEL-15 Drug Patent Profile
✉ Email this page to a colleague
When do Sulfacel-15 patents expire, and when can generic versions of Sulfacel-15 launch?
Sulfacel-15 is a drug marketed by Optopics and is included in one NDA.
The generic ingredient in SULFACEL-15 is sulfacetamide sodium. There are three drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the sulfacetamide sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Sulfacel-15
A generic version of SULFACEL-15 was approved as sulfacetamide sodium by SANDOZ on October 18th, 1988.
Summary for SULFACEL-15
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 117 |
| Patent Applications: | 5,073 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | SULFACEL-15 at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for SULFACEL-15
US Patents and Regulatory Information for SULFACEL-15
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Optopics | SULFACEL-15 | sulfacetamide sodium | SOLUTION/DROPS;OPHTHALMIC | 080024-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
